Richard van den Broek - 08 Apr 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVS	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	08 Apr 2025	Common Stock	30,000	$2.82	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from April 8, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.